UC San Diego Health, the region’s only academic medical center, delivers world-class care and translates groundbreaking research into promising new treatments for patients.
Hanna and Mark Gleiberman give $12 Million to UC San Diego to support the internationally recognized head and neck cancer center at UC San Diego Health. Funding will support research and patient experience.
UC San Diego launches new Center for Fluorescence-Guided Surgery. The center builds upon Roger Tsien’s legacy, delivering a new caliber of surgical precision to treat patients with tumors and disease of all types, identifying unhealthy tissues with a fluorescent glow.
A grant awarded to UC San Diego will allow researchers to continue working with law enforcement and health professionals to develop educational programs and interventions that reduce traffic-related injuries and deaths.
An international team of researchers has broadened and deepened understanding of how inherited retinal dystrophies (IRDs) affect different populations of people and, in the process, have identified new gene variants that may cause the diseases.
After analyzing the genomes of more 250,000 military veterans, researchers have identified 18 specific, fixed positions on chromosomes that appear associated with post-traumatic stress disorder. The findings may point to new therapeutic drug targets.
An international team of scientists led by researchers at University of California San Diego School of Medicine employed an array of next-generation sequencing and gene-editing tools, such as CRISPR, to map the molecular dependencies – and thus vulnerabilities – of pancreatic cancer stem cells.
Becker's Hospital Review, September 24
Becker's Clinical Leadership, September 28
STAT News, September 29
FOX 5/KUSI, September 30
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
